Carpenter Karen D, Gray C Allison, Bryan Tina M, Welsh Thomas H, Spencer Thomas E
Center for Animal Biotechnology and Genomics, Department of Animal Science, Texas A&M University, College Station, Texas 77843-2471, USA.
Biol Reprod. 2003 Aug;69(2):708-17. doi: 10.1095/biolreprod.103.015990. Epub 2003 Apr 16.
Postnatal development of the ovine uterus between birth and Postnatal Day (PND) 56 involves differentiation of the endometrial glandular epithelium from the luminal epithelium followed by tubulogenesis and branching morphogenesis. These critical events coincide with expression of estrogen receptor alpha (ERalpha) by nascent endometrial glands and stroma. To test the working hypothesis that estrogen and uterine ERalpha regulate uterine growth and endometrial gland morphogenesis in the neonatal ewe, ewes were treated daily from birth (PND 0) to PND 55 with 1) saline and corn oil as a vehicle control (CX), 2) estradiol-17 beta (E2) valerate (EV), an ERalpha agonist, 3) EM-800, an ERalpha antagonist, or 4) CGS 20267, a nonsteroidal aromatase inhibitor. On PND 14, ewes were hemihysterectomized, and the ipsilateral oviduct and ovary were removed. The remaining uterine horn, oviduct, and ovary were removed on PND 56. Treatment with CGS 20267 decreased plasma E2 levels, whereas EM-800 had no effect compared with CX ewes. Uterine horn weight and length were not affected by EM-800 or CGS 20267 but were decreased in EV ewes on PND 56. On PND 14 and PND 56, treatment with EV decreased endometrial thickness but increased myometrial thickness. The numbers of ductal gland invaginations and endometrial glands were not affected by CGS but were lower in EM-800 ewes on PND 56. Exposure to EV completely inhibited endometrial gland development and induced luminal epithelial hypertrophy but did not alter uterine cell proliferation. Exposure to EV substantially decreased expression of ERalpha, insulin-like growth factor (IGF) I, and IGF-II in the endometrium. Results indicate that circulating E2 does not regulate endometrial gland differentiation or development. Although ERalpha does not regulate initial differentiation of the endometrial glandular epithelium, results indicate that ERalpha does regulate, in part, coiling and branching morphogenesis of endometrial glands in the neonatal ewe. Ablation of endometrial gland genesis by EV indicates that postnatal uterine development is extremely sensitive to the detrimental effects of inappropriate steroid exposure.
绵羊子宫在出生至出生后第56天(PND 56)的产后发育过程包括子宫内膜腺上皮从腔上皮分化出来,随后进行小管形成和分支形态发生。这些关键事件与新生子宫内膜腺体和基质中雌激素受体α(ERα)的表达同时发生。为了验证雌激素和子宫ERα调节新生母羊子宫生长和子宫内膜腺体形态发生这一工作假设,从出生(PND 0)至PND 55每天对母羊进行如下处理:1)用生理盐水和玉米油作为载体对照(CX);2)戊酸雌二醇-17β(E2)(EV),一种ERα激动剂;3)EM - 800,一种ERα拮抗剂;4)CGS 20267,一种非甾体芳香化酶抑制剂。在PND 14时,对母羊进行半子宫切除术,并切除同侧输卵管和卵巢。在PND 56时切除剩余的子宫角、输卵管和卵巢。用CGS 20267处理可降低血浆E2水平,而与CX母羊相比,EM - 800没有影响。子宫角重量和长度不受EM - 800或CGS 20267影响,但在PND 56时,EV母羊的子宫角重量和长度降低。在PND 14和PND 56时,用EV处理可降低子宫内膜厚度,但增加子宫肌层厚度。导管腺内陷和子宫内膜腺体的数量不受CGS影响,但在PND 56时,EM - 800处理的母羊数量较少。暴露于EV完全抑制了子宫内膜腺体发育并诱导了腔上皮肥大,但未改变子宫细胞增殖。暴露于EV显著降低了子宫内膜中ERα、胰岛素样生长因子(IGF)I和IGF - II的表达。结果表明,循环E2不调节子宫内膜腺体的分化或发育。虽然ERα不调节子宫内膜腺上皮的初始分化,但结果表明ERα在一定程度上确实调节新生母羊子宫内膜腺体的卷曲和分支形态发生。EV对子宫内膜腺体发生的消融表明,产后子宫发育对不适当类固醇暴露的有害影响极其敏感。